Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

30 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Pretransplant comorbidities maintain their impact on allogeneic stem cell transplantation outcome 5 years posttransplant: a retrospective study in a single german institution.
Chemnitz JM, Chakupurakal G, Bäßler M, Holtick U, Theurich S, Shimabukuro-Vornhagen A, Leitzke S, Von Bergwelt-Baildon MS, Scheid C. Chemnitz JM, et al. Among authors: chakupurakal g. ISRN Hematol. 2014 Mar 5;2014:853435. doi: 10.1155/2014/853435. eCollection 2014. ISRN Hematol. 2014. PMID: 24729881 Free PMC article.
Nonmyeloablative allogeneic stem cell transplantation for chronic lymphocytic leukaemia offers the possibility of disease control with minimal morbidity and mortality--a single institution experience.
Chakupurakal G, Leitzke S, Langerbeins P, Schiller J, Schneider PM, Holtick U, Shimabukuro-Vornhagen A, Theurich S, Chemnitz J, Hallek M, von Bergwelt-Baildon M, Scheid C. Chakupurakal G, et al. Ann Hematol. 2015 Oct;94(10):1717-25. doi: 10.1007/s00277-015-2449-1. Epub 2015 Aug 12. Ann Hematol. 2015. PMID: 26259502
Brentuximab vedotin combined with donor lymphocyte infusions for early relapse of Hodgkin lymphoma after allogeneic stem-cell transplantation induces tumor-specific immunity and sustained clinical remission.
Theurich S, Malcher J, Wennhold K, Shimabukuro-Vornhagen A, Chemnitz J, Holtick U, Krause A, Kobe C, Kahraman D, Engert A, Scheid C, Chakupurakal G, Hallek M, von Bergwelt-Baildon M. Theurich S, et al. Among authors: chakupurakal g. J Clin Oncol. 2013 Feb 10;31(5):e59-63. doi: 10.1200/JCO.2012.43.6832. Epub 2012 Dec 26. J Clin Oncol. 2013. PMID: 23269992 No abstract available.
Anti-thymocyte globulins for post-transplant graft-versus-host disease prophylaxis-A systematic review and meta-analysis.
Theurich S, Fischmann H, Chakupurakal G, Shimabukuro-Vornhagen A, Chemnitz JM, Holtick U, Rothe A, Scheid C, Hallek M, Skoetz N, von Bergwelt-Baildon M. Theurich S, et al. Among authors: chakupurakal g. Crit Rev Oncol Hematol. 2013 Oct;88(1):178-86. doi: 10.1016/j.critrevonc.2013.03.009. Epub 2013 Apr 2. Crit Rev Oncol Hematol. 2013. PMID: 23561334 Review.
OCTET-CY: a phase II study to investigate the efficacy of post-transplant cyclophosphamide as sole graft-versus-host prophylaxis after allogeneic peripheral blood stem cell transplantation.
Holtick U, Chemnitz JM, Shimabukuro-Vornhagen A, Theurich S, Chakupurakal G, Krause A, Fiedler A, Luznik L, Hellmich M, Wolf D, Hallek M, von Bergwelt-Baildon M, Scheid C. Holtick U, et al. Among authors: chakupurakal g. Eur J Haematol. 2016 Jan;96(1):27-35. doi: 10.1111/ejh.12541. Epub 2015 Mar 16. Eur J Haematol. 2016. PMID: 25703164 Free PMC article. Clinical Trial.
FLAMSA reduced-intensity conditioning is equally effective in AML patients with primary induction failure as well as in first or second complete remission.
Holtick U, Shimabukuro-Vornhagen A, Chakupurakal G, Theurich S, Leitzke S, Burst A, Hallek M, von Bergwelt-Baildon M, Scheid C, Chemnitz JM. Holtick U, et al. Among authors: chakupurakal g. Eur J Haematol. 2016 May;96(5):475-82. doi: 10.1111/ejh.12615. Epub 2015 Aug 25. Eur J Haematol. 2016. PMID: 26132980
Persistent CMV infection after allogeneic hematopoietic stem cell transplantation in a CMV-seronegative donor-to-positive recipient constellation: Development of multidrug resistance in the absence of anti-viral cellular immunity.
Herling M, Schröder L, Awerkiew S, Chakupurakal G, Holtick U, Kaiser R, Pfister H, Scheid C, Di Cristanziano V. Herling M, et al. Among authors: chakupurakal g. J Clin Virol. 2016 Jan;74:57-60. doi: 10.1016/j.jcv.2015.11.033. Epub 2015 Nov 30. J Clin Virol. 2016. PMID: 26672492
30 results